Riyadh – Mubasher: Saudi Chemical Company’s pharmaceutical sector has received SAR 180 million investments, while investments pumped into the company’s explosives sector reached SAR 200 million, managing director, Mohammed Al Badr, told CNBC.
The increase in the company’s capital will be funded by provisions and retained profits, the top official added.
In September, the general assembly of the Tadawul-listed company will discuss a proposed 33% capital hike, which – if approved – will increase capital to SAR 843 million.
Saudi Chemical Company’s net profit after zakat and tax grew 11.15% year-on-year to SAR 30.9 million during the second quarter of 2019.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2019 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
